Leading innovators are needed to join the second cohort of Investing in Innovation Africa (i3), a pan-African program for entrepreneurs creating the future of healthcare supply chains.
The i3 initiative, supported by the Bill & Melinda Gates Foundation and AmerisourceBergen, Merck Sharp & Dohme (MSD), Microsoft, and Chemonics, is assisting 60 promising early-stage and growth-stage businesses with their commercialization efforts.
In order to support companies’ growth and impact, the program links African-led supply chain innovators with donors, business partners, and government partners. Selected startups receive a US$50,000 award, customized investment readiness support, and targeted introductions to consumers to boost commercialization and impact. Choosing women-led businesses and those doing business in Francophone regions is a priority for i3.
You can apply online here until June 26.
On September 14, the startups that were chosen will be revealed. 31 innovators who improved access to health products across more than 24,000 hospitals, clinics, and pharmacies in 26 African nations made up the inaugural cohort, which was chosen in September 2022.